| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/28/2007 | CN1935013A Complete wheat embryo bud nutrient flour and its preparing method |
| 03/28/2007 | CN1307253C Chitosan water-retaining gel adhesive substrate materials and method for preparing same |
| 03/28/2007 | CN1306990C Multiple emulsions |
| 03/28/2007 | CN1306964C Decoy composition for treating and preventing inflammatory disease |
| 03/28/2007 | CN1306955C Sodium ferulic acid albumin nano granular preparation and its preparing method |
| 03/28/2007 | CN1306954C Use of a pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention |
| 03/28/2007 | CN1306952C Chinese traditional medicine for treating chronic pharyngolaryngitis and its preparing process |
| 03/28/2007 | CN1306951C Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and process for preparing the same |
| 03/28/2007 | CN1306950C Kidney-invigorating and Yang-strengthening medicine and method for preparing same |
| 03/28/2007 | CN1306948C Capsule for treating osteoporosis and its preparing method |
| 03/28/2007 | CN1306946C Snuffle dredging capsule |
| 03/28/2007 | CN1306941C Skin preparation for external use containing purpuricenus temminckii frass as the active ingredient |
| 03/28/2007 | CN1306940C Vitreoretinal tamponades based on fluorosilicone fluids |
| 03/28/2007 | CN1306939C Preparation of sustained released strips of chitin homandren tablet |
| 03/28/2007 | CN1306938C Combination for local use for preventing and treating ocular disease |
| 03/28/2007 | CN1306934C Pharmaceutical composition containing zaleplon and its preparation method |
| 03/28/2007 | CN1306933C Anisodamine ointment for treating frostbite and sclerema neonatorum and method for preparing same |
| 03/28/2007 | CN1306931C Capsule preparation |
| 03/28/2007 | CN1306930C Soft antiviral capsule and its prepn |
| 03/28/2007 | CN1306929C Ultrapure oral fludara formulation with a fast releasing active substance |
| 03/28/2007 | CN1306928C Method for preparing Chinese traditional medicine for treating laryngopharyngeal paresthesia |
| 03/28/2007 | CN1306919C Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 03/28/2007 | CN1306916C Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 03/28/2007 | CN1306867C Ectoparasiticidal aqueous suspension formulations of Spinosyn |
| 03/27/2007 | US7197359 Compositions for electroporation |
| 03/27/2007 | US7196180 Amide derivatives; scaffold for tissue regeneration; drug delivery biodegradable; tissue adhesive |
| 03/27/2007 | US7196179 gluconic acid reaction or hydrolysis of glucono delta lactone in water with lactic acid in the presence of calcium hydroxide ; hypocalcaemia, hyperparathyroidism, osteomalacia, rickets, symptomatic treatment of osteoporosis especially in menopause, to calcify in breast milk |
| 03/27/2007 | US7196145 Heterofunctional copolymers of glycerol and polyethylene glycol, their conjugates and compositions |
| 03/27/2007 | US7196074 Hormone replacement therapy |
| 03/27/2007 | US7196071 Methods of decreasing or preventing pain using spicamycin derivatives |
| 03/27/2007 | US7196064 Compositions of plant carbohydrates as dietary supplements |
| 03/27/2007 | US7195906 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome |
| 03/27/2007 | US7195820 Core-shell polymers having hydrophilic shells for improved shell coverage and anti-blocking properties |
| 03/27/2007 | US7195791 Method for production of archidonic acid |
| 03/27/2007 | US7195780 Nanoparticle delivery system |
| 03/27/2007 | US7195779 Particularly levothyroxine sodium; unit dosage form containing an alditol, a saccharide, and optionally further excipients |
| 03/27/2007 | US7195778 Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
| 03/27/2007 | US7195777 Method and apparatus for blowmoding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules |
| 03/27/2007 | US7195776 Patch stabilization of rods for treatment of cardiac muscle |
| 03/27/2007 | US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 03/27/2007 | US7195771 Water-soluble lotions for paper products |
| 03/27/2007 | US7195769 Bioavailability |
| 03/27/2007 | US7195766 Product and process for liquefaction of mucus or sputum |
| 03/27/2007 | US7195752 Surfactant compounds and uses thereof |
| 03/27/2007 | CA2431660C Stabilised radiopharmaceutical compositions |
| 03/27/2007 | CA2419290C Quick-disintegrating tablet in the buccal cavity and manufacturing method thereof |
| 03/27/2007 | CA2334408C Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures |
| 03/27/2007 | CA2312744C Apparatus and method for diluting nasal sprays containing addictive compounds |
| 03/27/2007 | CA2295810C Soluble coated chewable tablet |
| 03/27/2007 | CA2290479C A hot-type compress |
| 03/27/2007 | CA2267416C Method for producing liposomes with increased percent of compound encapsulated |
| 03/27/2007 | CA2258981C Device for the application of a film-forming composition |
| 03/27/2007 | CA2247520C Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
| 03/27/2007 | CA2209669C Composition and methods for transdermal delivery of acid-labile drugs |
| 03/27/2007 | CA2208149C Sustained release caffeine formulation |
| 03/27/2007 | CA2168879C Skin patches and methods for providing testosterone |
| 03/22/2007 | WO2007033372A2 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
| 03/22/2007 | WO2007033353A2 Chemical target-binding compositions |
| 03/22/2007 | WO2007033316A2 Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
| 03/22/2007 | WO2007032993A2 Surfactant systems for delivery of organic compounds |
| 03/22/2007 | WO2007032962A2 Compositions and methods for intranasal delivery of tricyclic cannabinoids |
| 03/22/2007 | WO2007032822A1 A system and a method for labeling a substrate |
| 03/22/2007 | WO2007032727A1 Particulate lipid pharmaceutical composition |
| 03/22/2007 | WO2007032688A1 Anthelmintic formulations |
| 03/22/2007 | WO2007032225A1 Liposome, method of producing liposome and method of controlling reaction in microreaction space |
| 03/22/2007 | WO2007032018A1 pH SENSITIVE NANOPARTICLE FORMULATION FOR ORAL DELIVERY OF PROTEINS/PEPTIDES |
| 03/22/2007 | WO2007031812A1 Chitosan-based particles |
| 03/22/2007 | WO2007031801A1 IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF |
| 03/22/2007 | WO2007031753A2 Topical film-forming monophasic formulations |
| 03/22/2007 | WO2007031621A2 Metronidazole-based dermatological foam and emulsions for the production thereof |
| 03/22/2007 | WO2007031620A2 Metronidazole-based dermatological foam and emulsions for the production thereof |
| 03/22/2007 | WO2007031152A1 Method and device for producing ball- or tubular-shaped synthetic membranes |
| 03/22/2007 | WO2007031133A1 Pharmaceutical composition |
| 03/22/2007 | WO2007030902A2 Improved pharmaceutical composition containing artichoke extract, and process for its production |
| 03/22/2007 | WO2006130048A3 The method of producing aqueous solution of vitaminized preparation, vitaminized preparation (variants) |
| 03/22/2007 | WO2006122914A3 Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous |
| 03/22/2007 | WO2006122905A3 A substantially water-free pressurised propellant mixture |
| 03/22/2007 | WO2006121964A3 Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders |
| 03/22/2007 | WO2006121963A3 Suspension formulations comprising an active principle, a poloxamer or meroxapol surfactant and a glycol, its use for the manufacture of a medicament for treating ophthalmic disorders |
| 03/22/2007 | WO2006106400A3 Capsules containing seminal material for artificial insemination |
| 03/22/2007 | WO2006102990A3 Tablet containing steroid hormones |
| 03/22/2007 | WO2006089843A3 Anti-misuse microparticulate oral drug form |
| 03/22/2007 | WO2005120605A8 Flow regulator |
| 03/22/2007 | WO2005058250A3 Methods of administering water-soluble prodrugs of propofol for extended sedation |
| 03/22/2007 | US20070066966 Implantable medical device |
| 03/22/2007 | US20070066920 Supple tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan |
| 03/22/2007 | US20070066812 Fibroblast growth factor homologous factor-2 and methods of use |
| 03/22/2007 | US20070066686 Infusion preparation containing (2r)-2-propyloctanoic acid as at the active ingredient |
| 03/22/2007 | US20070066578 5-Aminosalicylic acid solid preparation improved in discoloration and method of storing the same |
| 03/22/2007 | US20070066574 Myo-inositol hexaphosphate for topical use |
| 03/22/2007 | US20070066565 Cyclic maltosylmatose |
| 03/22/2007 | US20070066563 alkaline deproteination and subsequent elimination of water-soluble components consists in that the so obtained insoluble glucan is subsequently hydrated by wet grinding; heat sterilizing, results in a fungal polysaccharide with the beta -(1,3)-D-bond in the principal chain |
| 03/22/2007 | US20070066555 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066552 Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids |
| 03/22/2007 | US20070066528 Methods and compositions for treating polycystic ovary syndrome |
| 03/22/2007 | US20070065596 Plasma thin-film deposition method |
| 03/22/2007 | US20070065522 Administration of high potency platinum compound formulations by inhalation |
| 03/22/2007 | US20070065517 Modafinil Pharmaceutical Compositions |